GISTs are typically driven by mutations in the receptor tyrosine kinase oncogene (C-KIT) or the platelet-derived growth factor receptor α (PDGFRα), which account for 85% or 5–10% of all cases of GIST, respectively [3,4,5]. Here, KIT is linked to gastrointestinal stromal tumor.